BioGaia AB (Sweden) Performance
| BIOG-B Stock | SEK 130.10 1.70 1.32% |
On a scale of 0 to 100, BioGaia AB holds a performance score of 21. The firm shows a Beta (market volatility) of 0.18, which signifies not very significant fluctuations relative to the market. As returns on the market increase, BioGaia AB's returns are expected to increase less than the market. However, during the bear market, the loss of holding BioGaia AB is expected to be smaller as well. Please check BioGaia AB's standard deviation, total risk alpha, treynor ratio, as well as the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether BioGaia AB's price patterns will revert.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in BioGaia AB are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, BioGaia AB sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
| Begin Period Cash Flow | 1.5 B |
BioGaia |
BioGaia AB Relative Risk vs. Return Landscape
If you would invest 10,400 in BioGaia AB on November 20, 2024 and sell it today you would earn a total of 2,610 from holding BioGaia AB or generate 25.1% return on investment over 90 days. BioGaia AB is generating 0.3973% of daily returns and assumes 1.4676% volatility on return distribution over the 90 days horizon. Simply put, 13% of stocks are less volatile than BioGaia, and 93% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
BioGaia AB Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioGaia AB's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as BioGaia AB, and traders can use it to determine the average amount a BioGaia AB's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.2707
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BIOG-B | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.47 actual daily | 13 87% of assets are more volatile |
Expected Return
| 0.4 actual daily | 7 93% of assets have higher returns |
Risk-Adjusted Return
| 0.27 actual daily | 21 79% of assets perform better |
Based on monthly moving average BioGaia AB is performing at about 21% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioGaia AB by adding it to a well-diversified portfolio.
BioGaia AB Fundamentals Growth
BioGaia Stock prices reflect investors' perceptions of the future prospects and financial health of BioGaia AB, and BioGaia AB fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on BioGaia Stock performance.
| Return On Equity | 0.19 | |||
| Return On Asset | 0.1 | |||
| Profit Margin | 0.34 % | |||
| Operating Margin | 0.33 % | |||
| Current Valuation | 7.35 B | |||
| Shares Outstanding | 97.28 M | |||
| Price To Earning | 33.68 X | |||
| Price To Book | 4.77 X | |||
| Price To Sales | 8.01 X | |||
| Revenue | 1.1 B | |||
| EBITDA | 476.89 M | |||
| Cash And Equivalents | 1.48 B | |||
| Cash Per Share | 18.18 X | |||
| Total Debt | 10.4 M | |||
| Debt To Equity | 4.20 % | |||
| Book Value Per Share | 19.53 X | |||
| Cash Flow From Operations | 318.94 M | |||
| Earnings Per Share | 2.70 X | |||
| Total Asset | 2.21 B | |||
| Current Asset | 360 M | |||
| Current Liabilities | 71 M | |||
About BioGaia AB Performance
By analyzing BioGaia AB's fundamental ratios, stakeholders can gain valuable insights into BioGaia AB's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if BioGaia AB has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if BioGaia AB has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
BioGaia AB develops, markets, and sells probiotic products with documented health benefits worldwide. BioGaia AB was founded in 1990 and is headquartered in Stockholm, Sweden. BioGaia AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 144 people.Things to note about BioGaia AB performance evaluation
Checking the ongoing alerts about BioGaia AB for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for BioGaia AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Evaluating BioGaia AB's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate BioGaia AB's stock performance include:- Analyzing BioGaia AB's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether BioGaia AB's stock is overvalued or undervalued compared to its peers.
- Examining BioGaia AB's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating BioGaia AB's management team can have a significant impact on its success or failure. Reviewing the track record and experience of BioGaia AB's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of BioGaia AB's stock. These opinions can provide insight into BioGaia AB's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for BioGaia Stock analysis
When running BioGaia AB's price analysis, check to measure BioGaia AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioGaia AB is operating at the current time. Most of BioGaia AB's value examination focuses on studying past and present price action to predict the probability of BioGaia AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioGaia AB's price. Additionally, you may evaluate how the addition of BioGaia AB to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |